WALKER CANCER RESEARCH INSTITUTE INC (EIN 521233437) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1981

Legal Domicile

Principal Officer

STEVEN L BLUMENTHAL

Phone

5617387963

Tax Period

2024-01-01 to 2024-12-31

WALKER CANCER RESEARCH INSTITUTE INC, founded in 1981, is a community nonprofit in the Diseases & Disorders sector that reported $2.3M in total revenue in fiscal year 2024. Expenses of $3.0M exceeded revenue, resulting in a 32% operating deficit.

Mission

CANCER RESEARCH AND PUBLIC INFORMATION

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,119,251

Program Service Revenue $36,702

Investment Income $100,814

Other Revenue $16

TOTAL REVENUE $2,256,783

Expense Breakdown

Grants Paid $0

Salaries & Benefits $830,216

Fundraising Expenses $1,334,966

Program Expenses $1,153,291

Other Expenses $1,968,008

TOTAL EXPENSES $2,985,722

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,256,783	$2,253,387	+0.0%
Expenses	$2,985,722	$2,761,440	+0.1%
Net Income	$-728,939	$-508,053	+0.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$174,773

Total Directors

$446,642

Key Employees

$544,881

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
STEVEN L BLUMENTHAL	VICE PRESIDENT	40.00	Officer Director Key Emp Highest	$174,773	$0	$174,773
DR EDUARDO PALOMINO	SENIOR RESEARCH CHEMIST	40.00	Director Key Emp Highest	$174,773	$0	$174,773
ELSA PILARINOU	PROJECT COORDINATOR	40.00	Key Emp	$98,239	$0	$98,239
DR YUHAO REN	RESEARCH CHEMIST	40.00	Director Key Emp	$97,096	$0	$97,096

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,256,783	$2,985,722	$6,016,496	$-728,939
2023	$2,253,387	$2,761,440	$6,714,511	$-508,053
2022	$3,196,197	$3,536,274	$8,120,738	$-340,077
2021	$4,172,874	$4,549,589	$8,994,408	$-376,715
2020	$4,322,567	$4,310,205	$9,466,613	$12,362

WALKER CANCER RESEARCH INSTITUTE INC